REQUEST A DEMO
Total
USD $0.00
Search more companies

Laboratorios Metlen Pharma S A S (Colombia)

Main Activities: Other Activities Related to Credit Intermediation
Full name: Laboratorios Metlen Pharma S A S Profile Updated: January 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Laboratorios Metlen Pharma S A S is based in Colombia. The head office is in Bogota D.C.. It operates in the Other Activities Related to Credit Intermediation sector. It was incorporated on February 21, 1991. It currently has a total number of 6 (2012) employees. A growth of 4.48% was recorded in its total assets.

Headquarters
Cl 17 # 42 - 09
Bogota D.C.; Bogota D.C; Postal Code: 0607

Contact Details: Purchase the Laboratorios Metlen Pharma S A S report to view the information.

Basic Information
Total Employees:
Purchase the Laboratorios Metlen Pharma S A S report to view the information.
Outstanding Shares:
Purchase the Laboratorios Metlen Pharma S A S report to view the information.
Registered Capital:
Purchase the Laboratorios Metlen Pharma S A S report to view the information.
Incorporation Date:
February 21, 1991
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Laboratorios Metlen Pharma S A S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Operating profit (EBIT)
60.89%
Net Profit (Loss) for the Period
98.24%
Total assets
4.48%
Total equity
6.27%
Return on Equity (ROE)
2.73%
Quick Ratio
4.42%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?